Quick Links
Resources
About MyEczemaTeam
Powered By
Dr. Brian S. Kim is co-director for the Center for the Study of Itch and Sensory Disorders and associate professor of medicine at Washington University School of Medicine in St. Louis. Key discoveries from his laboratory include the first identification of group 2 innate lymphoid cells (ILC2s) in the skin of both mice and humans, and their role in the pathogenesis of atopic dermatitis or eczema. Most recently, he has discovered how the immune system directly regulates sensory neurons to modulate the sensation of itch and how natural killer cells may be used as an immunotherapy strategy for atopic dermatitis. These studies have revealed novel therapeutic strategies which have led to successful clinical trials for new drugs for atopic dermatitis. He has multiple patents pending that led to the formation of Nuogen Pharma, Inc. that is developing JAK inhibitors for chronic itching.
Your Privacy Choices